Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.

Pediatric cardiology - 1 Jan 2000

Chatrath R, Bell C M, Ackerman M J

Abstract excerpt

Beta-blocker therapy is one of the principal therapies for congenital long-QT syndrome (LQTS). However, breakthrough cardiac events occur while being treated with beta-blockers. We sought to determine the frequency of and clinical correlates underlying beta-blocker therapy failures in genotyped,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to ERG1 Potassium Channel
Share to Ether-A-Go-Go Potassium Channels

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to KCNQ Potassium Channels

Share to KCNQ1 Potassium Channel

Share to Patient Compliance

Share to Potassium Channels, Voltage-Gated

Share to Propranolol

Source

Identifiers

PMID: 15534720
DOI: 10.1007/s00246-003-0567-3

Genes

KCNH2
KCNQ1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-15534720-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.PMID 15534720Read ↗

High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures".Semantic proximity Read ↗

Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers.Semantic proximity Read ↗

Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects.Semantic proximity Read ↗

Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.Semantic proximity Read ↗

Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management.Semantic proximity Read ↗

Long QT syndrome in children in the era of implantable defibrillators.Semantic proximity Read ↗

Effective long-term control of cardiac events with beta-blockers in a family with a common LQT1 mutation.Semantic proximity Read ↗

Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era.Semantic proximity Read ↗

Repeat long QT syndrome genetic testing of phenotype-positive cases: prevalence and etiology of detection misses.Semantic proximity Read ↗

Congenital long QT syndrome in children identified by family screening.Semantic proximity Read ↗

Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome.Semantic proximity Read ↗

Efficacy of different beta-blockers in the treatment of long QT syndrome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.